Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OVID compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
OVID
Ovid Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
OVID
Ovid Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OVID
7
LGND
Ligand Pharmaceuticals
customer
TAK
Takeda
customer
—
Northwestern University
unlisted
supplier
—
AstraZeneca
unlisted
supplier
3 more · OVID chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
OVID
Ovid Therapeutics Inc.
Change
2.86
▲
+10.68%
· post 2.90
· delayed
Mkt cap
$503.9M
Revenue
$733,000
Q2 FY26
Revenue
$7M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,360.79
· delayed
After hours
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 6 '26
delayed
OVID
Ovid Therapeutics Inc.
vs
LLY
ELI Lilly & Co
2.86
▲
+10.68%
post 2.90
delayed
Price
1,360.90
▼
−0.28%
post 1,360.79
delayed
$503.9M
Mkt cap
$1.2T
Q2 FY26
$733,000
Revenue
$24.4B
Q3 FY26
FY25
$7M
Revenue
$65.2B
FY25
Change
Change
OVID
2.86
▲
+10.68%
vs
LLY
1,360.90
▼
−0.28%
After hours
Nov 6 '26
delayed